X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7413) 7413
Publication (330) 330
Book Review (23) 23
Dissertation (21) 21
Newsletter (12) 12
Conference Proceeding (7) 7
Book Chapter (6) 6
Magazine Article (5) 5
Newspaper Article (3) 3
Streaming Video (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5802) 5802
female (4617) 4617
middle aged (3733) 3733
epirubicin (3500) 3500
oncology (3467) 3467
epirubicin - administration & dosage (3421) 3421
adult (3023) 3023
antineoplastic combined chemotherapy protocols - therapeutic use (3020) 3020
aged (3013) 3013
chemotherapy (2354) 2354
male (2332) 2332
breast neoplasms - drug therapy (2123) 2123
index medicus (2027) 2027
cancer (1547) 1547
treatment outcome (1471) 1471
breast cancer (1448) 1448
doxorubicin (1395) 1395
fluorouracil - administration & dosage (1337) 1337
cyclophosphamide - administration & dosage (1290) 1290
antineoplastic combined chemotherapy protocols - adverse effects (1247) 1247
breast neoplasms - pathology (1151) 1151
epirubicin - adverse effects (1008) 1008
antineoplastic combined chemotherapy protocols - administration & dosage (945) 945
cisplatin - administration & dosage (924) 924
therapy (916) 916
epirubicin - therapeutic use (907) 907
cyclophosphamide (896) 896
chemotherapy, adjuvant (862) 862
anthracyclines (853) 853
drug administration schedule (800) 800
neoplasm staging (798) 798
cisplatin (782) 782
disease-free survival (764) 764
prognosis (743) 743
paclitaxel (711) 711
doxorubicin - administration & dosage (709) 709
combined modality therapy (694) 694
survival rate (685) 685
pharmacology & pharmacy (644) 644
carcinoma (640) 640
docetaxel (629) 629
fluorouracil (611) 611
survival (598) 598
survival analysis (583) 583
animals (581) 581
antibiotics, antineoplastic - administration & dosage (581) 581
follow-up studies (557) 557
paclitaxel - administration & dosage (533) 533
trial (525) 525
medicine & public health (512) 512
retrospective studies (509) 509
neoadjuvant therapy (507) 507
care and treatment (498) 498
prospective studies (498) 498
dose-response relationship, drug (496) 496
aged, 80 and over (491) 491
epirubicin - pharmacology (489) 489
adjuvant chemotherapy (462) 462
taxoids - administration & dosage (451) 451
surgery (438) 438
breast neoplasms - surgery (428) 428
neoadjuvant chemotherapy (419) 419
tumors (405) 405
research (404) 404
breast neoplasms - mortality (403) 403
time factors (395) 395
stomach neoplasms - drug therapy (393) 393
adenocarcinoma - drug therapy (388) 388
antineoplastic agents - therapeutic use (382) 382
analysis (374) 374
5-fluorouracil (372) 372
neoplasm metastasis (369) 369
cyclophosphamide - adverse effects (354) 354
adolescent (349) 349
deoxycytidine - analogs & derivatives (349) 349
methotrexate (341) 341
antibiotics, antineoplastic - therapeutic use (334) 334
phase-ii (333) 333
toxicity (333) 333
drug therapy (332) 332
doxorubicin - adverse effects (329) 329
methotrexate - administration & dosage (320) 320
fluorouracil - adverse effects (317) 317
combination (314) 314
adriamycin (307) 307
doxorubicin - therapeutic use (305) 305
trastuzumab (302) 302
cell line, tumor (297) 297
antibiotics, antineoplastic - adverse effects (291) 291
deoxycytidine - administration & dosage (291) 291
health aspects (291) 291
metastasis (290) 290
cyclophosphamide - therapeutic use (288) 288
mice (288) 288
randomized-trial (288) 288
antineoplastic agents - administration & dosage (287) 287
lymphatic metastasis (287) 287
etoposide - administration & dosage (285) 285
liver neoplasms - drug therapy (285) 285
remission induction (285) 285
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6785) 6785
Japanese (391) 391
Chinese (168) 168
German (111) 111
French (88) 88
Italian (53) 53
Spanish (31) 31
Russian (25) 25
Polish (21) 21
Hungarian (13) 13
Korean (9) 9
Bulgarian (5) 5
Portuguese (5) 5
Romanian (4) 4
Serbian (4) 4
Danish (3) 3
Czech (2) 2
Croatian (1) 1
Finnish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Controlled Release, ISSN 0168-3659, 11/2015, Volume 218, pp. 36 - 44
To develop a biodegradable polymeric drug delivery system for the treatment of ovarian cancer with the capacity for non-invasive fate monitoring, we designed... 
N-(2-hydroxypropyl)methacrylamide (HPMA) | FRET | Epirubicin | Ovarian carcinoma | VIVO | COMBINATION THERAPY | DOXORUBICIN | POLYMERIZATION | CANCER | CHEMISTRY, MULTIDISCIPLINARY | GEMCITABINE | DELIVERY | PACLITAXEL | N-(2-hydroxypropyl) methacrylamide (HPMA) | MULTIBLOCK | PHARMACOLOGY & PHARMACY | Carbocyanines - chemistry | Antibiotics, Antineoplastic - pharmacology | Carbocyanines - administration & dosage | Humans | Ovarian Neoplasms - pathology | Carbocyanines - pharmacology | Epirubicin - administration & dosage | Methacrylates - chemistry | Methacrylates - therapeutic use | Antibiotics, Antineoplastic - chemistry | Fluorescence Resonance Energy Transfer | Methacrylates - pharmacology | Female | Fluorescent Dyes - pharmacology | Ovarian Neoplasms - metabolism | Fluorescent Dyes - administration & dosage | Ovarian Neoplasms - drug therapy | Cell Survival - drug effects | Fluorescent Dyes - chemistry | Epirubicin - chemistry | Methacrylates - administration & dosage | Antibiotics, Antineoplastic - administration & dosage | Animals | Antibiotics, Antineoplastic - therapeutic use | Tumor Burden - drug effects | Mice, Nude | Cell Line, Tumor | Epirubicin - therapeutic use | Mice | Epirubicin - pharmacology | Polymerization | Care and treatment | Anthracyclines | Carcinoma | Cancer | Ovarian cancer | N-(2-Hydroxypropyl)methacrylamide (HPMA)
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 05/2017, Volume 523, Issue 1, pp. 203 - 216
Journal Article
Investigational New Drugs, ISSN 0167-6997, 06/2017, Volume 35, Issue 3, pp. 307 - 314
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 07/2017, Volume 258, pp. 95 - 107
Multimodal imaging-guided synergistic combination therapy has shown great potential for cancer treatment. However, the nanocarrier-based theranostic systems... 
Indocyanine green | Epirubicin | Co-self-assembly | Dual-modal imaging | Combination chemo-photothermal therapy | Small molecular nanodrugs | PHOTODYNAMIC THERAPY | COMBINATION THERAPY | CARRIER-FREE | CHEMISTRY, MULTIDISCIPLINARY | CANCER-THERAPY | DELIVERY | TUMOR ACCUMULATION | MULTIFUNCTIONAL NANOPARTICLES | IN-VIVO | PHARMACOLOGY & PHARMACY | PURE NANODRUGS | Nanoparticles - chemistry | Humans | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Epirubicin - administration & dosage | Breast Neoplasms - therapy | Indocyanine Green - chemistry | Phototherapy - methods | Theranostic Nanomedicine - methods | MCF-7 Cells | Nanoparticles - therapeutic use | Photoacoustic Techniques - methods | Female | Breast Neoplasms - diagnostic imaging | Hyperthermia, Induced - methods | Optical Imaging - methods | Coloring Agents - administration & dosage | Epirubicin - chemistry | Indocyanine Green - administration & dosage | Models, Molecular | Antineoplastic Agents - chemistry | Animals | Mice, Nude | Cell Line, Tumor | Epirubicin - therapeutic use | Combined Modality Therapy - methods | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Drug Delivery Systems - methods | Coloring Agents - chemistry | Drugs | Nanoparticles | Chemotherapy | Anthracyclines | Drug delivery systems | Fluorescence | Pharmaceutical industry | Drug approval | Vehicles | Cancer | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Colloids and Surfaces B: Biointerfaces, ISSN 0927-7765, 04/2015, Volume 128, pp. 448 - 456
Journal Article
Cancer Letters, ISSN 0304-3835, 2012, Volume 330, Issue 1, pp. 74 - 83
Abstract Multidrug resistance (MDR) is one of the major reasons for the failure of cancer chemotherapy. A newly reported liposome carrier, propylene glycol... 
Hematology, Oncology and Palliative Medicine | Cancer targeted therapy | Propylene glycol liposomes | Epirubicin | Multidrug resistance | TUMOR-CELL LINES | DRUG | VITRO | METASTASIS | BIODISTRIBUTION | DELIVERY | REVERSAL | PLURONIC L61 | TRANSPORT | ONCOLOGY | IN-VIVO | Antibiotics, Antineoplastic - pharmacology | Drug Resistance, Multiple | Liposomes - administration & dosage | Humans | Drug Resistance, Neoplasm | Epirubicin - administration & dosage | Mammary Neoplasms, Experimental - metabolism | Breast Neoplasms - metabolism | Propylene Glycol - administration & dosage | Antibiotics, Antineoplastic - chemistry | Mammary Neoplasms, Experimental - pathology | Female | Antibiotics, Antineoplastic - pharmacokinetics | Propylene Glycol - chemistry | Mammary Neoplasms, Experimental - drug therapy | Cell Growth Processes - drug effects | Epirubicin - chemistry | Rats | Random Allocation | Breast Neoplasms - drug therapy | Rats, Sprague-Dawley | Antibiotics, Antineoplastic - administration & dosage | Liposomes - chemistry | Animals | Breast Neoplasms - pathology | Cell Line, Tumor | Epirubicin - pharmacokinetics | Epirubicin - pharmacology | Drug resistance in microorganisms | Anthracyclines | Fluorescence | Breast cancer | Permeability | Cells | Membrane proteins | Propylene | Prevention | Chemotherapy | Analysis | Physiological aspects | Health aspects | Cancer
Journal Article
Journal Article